TGA (and early sales) is not the near term catalyst any longer given the proposed trial design has been developed to ensure all governing bodies are comfortable and then get on board. That's why we're flatlining in the $2s as the market resets it's expectations. PR will as a result likely become increasingly uncomfortable with the market's ongoing treatment of PAR and look to force the issue via a deal later this year. All IMO of course......and that it won't really matter if we receive such news in CY21 or CY22 but it is coming.
p.s. I'm sure PR will see Bell Potter's price target as somewhat underwhelming despite Coppo's personal call.
research reports and media, page-1071
-
- There are more pages in this discussion • 3,341 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $59.66K | 241.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78837 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 36290 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |